aUniversity of Chicago, Department of Psychiatry and Behavioral Neuroscience, Chicago, Illinois, USA
bDepartment of Psychiatry, University of Cambridge, Cambridge, UK
cDepartment of Psychiatry, Faculty of Medicine, University of Southampton; and Southern Health NHS Foundation Trust, Southampton, UK.
Received 1 March 2021 Accepted 26 April 2021
ClinicalTrials.gov Identifier: NCT03348930
Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.intclinpsychopharm.com
Correspondence to Jon E. Grant, JD, MD, MPH, Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Pritzker School of Medicine, 5841 S. Maryland Avenue, MC-3077, Chicago, IL 60637, USA, Tel: +773 834 1325; e-mail: [email protected]
留言 (0)